|
1
|
Shao Y, Lv C, Wu C, Zhou Y and Wang Q:
Mir-217 promotes inflammation and fibrosis in high glucose cultured
rat glomerular mesangial cells via Sirt1/HIF-1α signaling pathway.
Diabetes Metab Res Rev. 32:534–543. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chang ZL, Beezhold DH, Personius CD and
Shen ZL: Fibronectin cell-binding domain triggered transmembrane
signal transduction in human monocytes. J Leukoc Biol. 53:79–85.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu Y, Wang Z, Yin W, Li Q, Cai M, Zhang
C, Xiao J, Hou H, Li H and Zu X: Severe insulin resistance and
moderate glomerulosclerosis in a minipig model induced by
high-fat/high-sucrose/high-cholesterol diet. Exp Anim. 56:11–20.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yiu WH, Lin M and Tang SC: Toll-like
receptor activation: From renal inflammation to fibrosis. Kidney
Int Suppl (2011). 4:20–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fragopoulou E, Iatrou C, Antonopoulou S,
Ruan XZ, Fernando RL, Powis SH, Moorhead JF and Varghese Z:
Platelet-activating factor (PAF) increase intracellular lipid
accumulation by increasing both LDL and scavenger receptors in
human mesangial cells. J Lab Clin Med. 147:281–289. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Koya D, Jirousek MR, Lin YW, Ishii H,
Kuboki K and King GL: Characterization of protein kinase C beta
isoform activation on the gene expression of transforming growth
factor-beta, extracellular matrix components, and prostanoids in
the glomeruli of diabetic rats. J Clin Invest. 100:115–126. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Banach M, Dinca M, Ursoniu S, Serban MC,
Howard G, Mikhailidis DP, Nicholls S, Lip GY, Glasser S, Martin SS,
et al: A PRISMA-compliant systematic review and meta-analysis of
randomized controlled trials investigating the effects of statin
therapy on plasma lipid concentrations in HIV-infected patients.
Pharmacol Res. 111:343–356. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao L, Zhao Q, Zhou Y, Zhao Y and Wan Q:
Atorvastatin may correct dyslipidemia in adult patients at risk for
Alzheimer's disease through an anti-inflammatory pathway. CNS
Neurol Disord Drug Targets. 15:80–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song CY, Kim BC and Lee HS: Lovastatin
inhibits oxidized low-density lipoprotein-induced plasminogen
activator inhibitor and transforming growth factor-beta1 expression
via a decrease in Ras/extracellular signal-regulated kinase
activity in mesangial cells. Transl Res. 151:27–35. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kom GD, Schwedhelm E, Maas R, Schneider L,
Benndorf R and Böger RH: Impact of atorvastatin treatment on
platelet-activating factor acetylhydrolase and
15-F(2trans)-isoprostane in hypercholesterolaemic patients. Br J
Clin Pharmacol. 63:672–679. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou SX, Lei MX, Zhao JJ and Chen HL: The
study of the effects of platelet activating factor (PAF) on the
relation between the endothelial cell and mesangial cells exposed
to high glucose and high lysophosphatidylcholine. Chin J Diabetes.
18:591–593. 2010.(In Chinese).
|
|
12
|
Sraer JD, Delarue F, Hagege J, Feunteun J,
Pinet F, Nguyen G and Rondeau E: Stable cell lines of T-SV40
immortalized human glomerular mesangial cells. Kidney Int.
49:267–270. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu D, Qian F, Wu Y, Jones DS, Rowe C,
Narum DL, Duffy P, Miller LH and Saul A: Determination of protein
concentration for protein-protein conjugates using ultraviolet
absorption. J Immunol Methods. 387:317–321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meier M, Park JK, Overheu D, Kirsch T,
Lindschau C, Gueler F, Leitges M, Menne J and Haller H: Deletion of
protein kinase C-beta isoform in vivo reduces renal hypertrophy but
not albuminuria in the streptozotocin-induced diabetic mouse model.
Diabetes. 56:346–354. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tahara A, Tsukada J, Tomura Y, Yatsu T and
Shibasaki M: Vasopressin increases type IV collagen production
through the induction of transforming growth factor-beta secretion
in rat mesangial cells. Pharmacol Res. 57:142–150. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Davignon J: Emphasis on pleiotropic
effects, a new paradigm shift? Coron Artery Dis. 15:223–225. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Alfaro V: Role of histamine and
platelet-activating factor in allergic rhinitis. J Physiol Biochem.
60:101–111. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsoupras AB, Fragopoulou E, Nomikos T,
Iatrou C, Antonopoulou S and Demopoulos CA: Characterization of the
de novo biosynthetic enzyme of platelet activating factor,
DDT-insensitive cholinephosphotransferase, of human mesangial
cells. Mediators Inflamm. 2007:276832007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reznichenko A and Korstanje R: The role of
platelet-activating factor in mesangial pathophysiology. Am J
Pathol. 185:888–896. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Honda ZI, Ishii S and Shimizu T:
Platelet-activating factor receptor. J Biochem. 131:773–779. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Asano KK, Taniguchi SS, Nakao AA, Watanabe
TT and Kurokawa KK: Distribution of platelet activating factor
receptor mRNA along the rat nephron segments. Biochem Biophys Res
Commun. 225:352–357. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ruiz-Ortega M, Bustos C, Plaza JJ and
Egido J: Overexpression of extracellular matrix proteins in renal
tubulointerstitial cells by platelet-activating-factor stimulation.
Nephrol Dial Transplant. 13:886–892. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ruiz-Ortega M, Largo R, Bustos C,
Gómez-Garre D and Egido J: Platelet-activating factor stimulates
gene expression and synthesis of matrix proteins in cultured rat
and human mesangial cells: Role of TGF-beta. J Am Soc Nephrol.
8:1266–1275. 1997.PubMed/NCBI
|
|
25
|
Kopecky C, Genser B, Drechsler C, Krane V,
Kaltenecker CC, Hengstschläger M, März W, Wanner C, Säemann MD and
Weichhart T: Quantification of HDL proteins, cardiac events, and
mortality in patients with type 2 diabetes on hemodialysis. Clin J
Am Soc Nephrol. 10:224–231. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tremoulet AH: The role of statins in
inflammatory vasculitides. Autoimmunity. 48:177–180. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kolavennu V, Zeng L, Peng H, Wang Y and
Danesh FR: Targeting of RhoA/ROCK signaling ameliorates progression
of diabetic nephropathy independent of glucose control. Diabetes.
57:714–723. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mooradian AD and Haas M: Statins
ameliorate glomerular permeability changes in
streptozotocin-induced diabetic rats. Am J Ther. 14:41–45. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song Y, Li C and Cai L: Fluvastatin
prevents nephropathy likely through suppression of connective
tissue growth factor-mediated extracellular matrix accumulation.
Exp Mol Pathol. 76:66–75. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jaikumkao K, Pongchaidecha A, Chattipakorn
N, Chatsudthipong V, Promsan S, Arjinajarn P and Lungkaphin A:
Atorvastatin improves renal organic anion transporter 3 and renal
function in gentamicin-induced nephrotoxicity in rats. Exp Physiol.
101:743–753. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pahan K: Lipid-lowering drugs. Cell Mol
Life Sci. 63:1165–1178. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tsoupras AB, Iatrou C, Frangia C and
Demopoulos CA: The implication of platelet activating factor in
cancer growth and metastasis: Potent beneficial role of
PAF-inhibitors and antioxidants. Infect Disord Drug Targets.
9:390–399. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Noto H, Hara M, Karasawa K, Iso-O N, Satoh
H, Togo M, Hashimoto Y, Yamada Y, Kosaka T, Kawamura M, et al:
Human plasma platelet activating factor acetylhydrolase binds to
all them urine lipoproteins, conferring protection again
stoxidatives tress. Arterioscler Thromb Vasc Biol. 23:829–835.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Park CW, Kim JH, Lee JH, Kim YS, Ahn HJ,
Shin YS, Kim SY, Choi EJ, Chang YS and Bang BK: High
glucose-induced intercellular adhesion molecule-1(ICAM-1)
expression through an osmotic effect in rat mesangial cells is
PKC-NF-kappa B-dependent. Diabetologia. 43:1544–1553. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang F, Sun D, Chen J, Guan N, Huo X and
Xi H: Simvastatin attenuates angiotensin II-induced inflammation
and oxidative stress in human mesangial cells. Mol Med Rep.
11:1246–1251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vincent JL, Spapen H, Bakker J, Webster NR
and Curtis L: Phase II multicenter clinical study of the
platelet-activating factor receptor antagonist BB-882 in the
treatment of sepsis. Crit Care Med. 28:638–642. 2000. View Article : Google Scholar : PubMed/NCBI
|
